Diabetes in Pregnancy
  • Odip logo 1024px
  • Screenshot 20171204 155917
  • Screenshot 20171204 155926
  • Screenshot 20171204 155942
  • Screenshot 20171204 160004
  • Screenshot 20171204 160048
  • Screenshot 2017 12 04 16 14 58
  • Screenshot 2017 12 04 16 15 19
  • Screenshot 2017 12 04 16 15 39
  • Screenshot 2017 12 04 16 16 07
  • Screenshot 2017 12 04 16 16 07
  • Simulator screen shot 4 dec 2017  14.31.10
  • Simulator screen shot 4 dec 2017  14.31.20
  • Simulator screen shot 4 dec 2017  14.31.30
  • Simulator screen shot 4 dec 2017  14.31.45
  • Simulator screen shot 4 dec 2017  14.32.15
  • Simulator screen shot 4 dec 2017  14.26.54
  • Simulator screen shot 4 dec 2017  14.27.13
  • Simulator screen shot 4 dec 2017  14.27.32
  • Simulator screen shot 4 dec 2017  14.28.34
  • Simulator screen shot 4 dec 2017  14.29.50
Available For
Android
iOS

Diabetes in Pregnancy

Oxford University Press

This Oxford University Press app-book, Diabetes in Pregnancy, is developed by MedHand. Improve your performance with relevant, valid material which is accessed quickly and with minimal effort in the palm of your hand using MedHand's patented technology.

THIS APP-BOOK includes unique functions such as:

  • A powerful search
  • Bookmarks
  • Complete set of medical calculators; Body Mass Index, Peak Expiratory Flows, Dehydration Correction Calculator and more
  • Highlighting
  • History
  • Notes and picture notes

About this title

Oxford Diabetes Library Series

  • Portable, accessible format for quick-reference
  • Helpful "Key Points" sections at the start of each chapter

Diabetes is one of the most common medical conditions to complicate pregnancy. Gestational diabetes (diabetes with onset or first recognition in pregnancy) may complicate between 2 and 20% of pregnancies depending on the criteria used. Type 1 or Type 2 diabetes complicates over 1 in 300 pregnancies, and both have major implications for mother and child.

The management of diabetes during pregnancy has seen a number of major innovations in recent years. Insulin analogues have been introduced, and technical innovations include improvements in insulin pumps and the development of continuous glucose monitoring devices. The evidence base for the management of gestational diabetes has improved markedly, and the investigations based around the Hyperglycaemia and Adverse Pregnancy Outcomes (HAPO) study promise to revolutionise our understanding of the risks of adverse outcomes in pregnancy. The Australian Carbohydrate Intolerance Study (ACHOIS) has demonstrated that identification and glycaemic management of gestational diabetes leads to reduction in birth weight, macrosomia and adverse pregnancy outcomes. Finally, recent randomised control trials have explored use of oral hypoglycaemics (metformin, glibenclamide) in pregnancy.

Authors: Robert Lindsay

Purchase Options
Price
£32.99 GBP
£32.99 GBP
£32.99 GBP
Look for similar items
images

Get all the clinical decision support you need, at your fingertips

MedHand is now called Indextra. Our brand new app* gives you a complete medical library for a low subscription fee, instead of buying books one by one. It includes the Oxford Handbooks, Stahl’s, Maudsley, BNF, BNF-C, TNM and most of the 500+ other medical books we’ve been selling under the MedHand brand.

*Available in App Store. Android and PC/MAC coming soon.

images